Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population-Reference-Cited by-同舟云学术

Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine in the elderly Belgian population

Published:2023-07-04 Issue:1 Volume:22 Page:608-619
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Marbaix Sophie¹²,Dauby Nicolas³⁴^ORCID,Mould-Quevedo Joaquin⁵

Affiliation:

1. Global Health Economics, SNB Management, Soignies, Belgium

2. Health Economics, Faculty of Medicine and Pharmacy, Research Institute for Health Sciences and Technology, University of Mons–UMONS, Mons, Belgium

3. Department of Infectious Diseases, CHU Saint-Pierre, Brussels, Belgium

4. School of Public Health, Université Libre de Bruxelles (ULB), Brussels, Belgium

5. CSL Seqirus, Summit, NJ, USA

Funder

Seqirus CSL

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2023.2229917

Reference53 articles.

1. WHO. Influenza (Seasonal); 2023. [cited 2023 June28]. https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal)

2. Bossuyt N, Thomas I, Barbezange C, et al. Surveillance des infections à influenza. Rapport épidémiologique saison 2018-2019. Brussels: Sciensano; 2019.

3. Beutels P, Vandendijck Y, Willem L, et al. Seasonal influenza vaccination: prioritizing children or other target groups? Belgium: Belgian Health Care Knowledge Centre (KCE); 2013.

4. Population-Based Study on Incidence, Risk Factors, Clinical Complications and Drug Utilisation Associated with Influenza in the United Kingdom

5. Ministry of Health. Nombre de séjours hospitaliers par diagnostic ICD-10 - RHM. Brussels: Ministry of Health; 2021.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness of recombinant influenza vaccine compared with standard dose influenza vaccine in adults 18–64 years of age;Vaccine;2024-10

2. Cost-Effectiveness of Adjuvanted Quadrivalent Influenza Vaccine for Adults over 65 in France;Vaccines;2024-05-24

3. Use of Adjuvanted Quadrivalent Influenza Vaccine in Older-Age Adults: A Systematic Review of Economic Evidence;Vaccines;2024-05-10

4. Cost-effectiveness of the adjuvanted quadrivalent influenza vaccine for older adults in South Korea;Human Vaccines & Immunotherapeutics;2024-05-07

5. Influenza vaccination – still a priority;Practice Nursing;2023-12-02